Black Diamond Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Black Diamond Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2018 to Q3 2024.
  • Black Diamond Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 56.5M shares, a 9.46% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 56.5M +4.89M +9.46% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 56.4M +19.9M +54.4% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 52.5M +16M +43.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 51.6M +15.2M +41.8% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 51.6M +15.3M +42% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 36.5M +218K +0.6% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 36.5M +224K +0.62% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 36.4M +200K +0.55% Dec 31, 2022 10-K 2024-03-12
Q3 2022 36.4M +137K +0.38% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 36.3M +110K +0.3% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 36.3M +140K +0.39% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 36.2M +156K +0.43% Dec 31, 2021 10-K 2023-03-09
Q3 2021 36.2M +265K +0.74% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 36.2M +295K +0.82% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 36.1M +237K +0.66% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 36.1M +33.8M +1513% Dec 31, 2020 10-K 2022-03-17
Q3 2020 36M Sep 30, 2020 10-Q 2020-11-10
Q2 2020 35.9M Jun 30, 2020 10-Q 2020-08-11
Q1 2020 35.9M Mar 31, 2020 10-Q 2020-05-12
Q4 2019 2.24M +63K +2.9% Dec 31, 2019 10-K 2021-03-25
Q4 2018 2.17M Dec 31, 2018 10-K 2020-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.